comparemela.com

Latest Breaking News On - Importation authorisation - Page 1 : comparemela.com

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA)

LONDON, March 12, 2024 (GLOBE NEWSWIRE) Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that following the most recent GMP

United statesUnited kingdomCity ofSusana noonanOlivia manserDave brochuJulia wilsonExchange commission onSa noonan communicationsExchange commissionAutolu nucleusImportation authorisationChief technology officerOrphan drug designationOrphan medical product designationRegenerative medicine advanced therapy

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site

12.03.2024 - LONDON, March 12, 2024 (GLOBE NEWSWIRE) - Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that following the most recent GMP inspection by . Seite 1

City ofUnited kingdomAutolu nucleusImportation authorisationAutolus therapeutics chartUtolus therapeutics kursUtolus therapeutics aktie

Essential Pharma strengthens its global operating platform in preparation for next stage of growth

Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the strengthening of its operating platform to support the next phase of its growth, with the granting of new .

United kingdomSteen vansgaardMalta medicines authorityEuropean unionEssential pharmaGood distribution practiceImportation authorisationGood manufacturing practiceMalta medicines

Essential Pharma strengthens its global operating platform in preparation for next stage of growth

EGHAM, England, Aug. 25, 2022 /PRNewswire/ Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, "at risk" products essential to patients

United kingdomFrazer hallSteen vansgaardKostenloser wertpapierhandelSteen vangsgaardEvelyn mccormackMalta medicines authorityEuropean unionEssential pharmaGood distribution practiceImportation authorisationGood manufacturing practiceMalta medicinesGyrus capital

vimarsana © 2020. All Rights Reserved.